Beijing Biotech

This early-stage trial is testing a new type of cell therapy for adults with advanced liver cancer that has stopped responding to standard treatments. Researchers are using specially engineered immune cells (CAR-NK cells) designed to recognize and attack cancer cells using two di…

This early-stage trial is testing a new type of immune cell therapy for adults with advanced bladder cancer that has stopped responding to standard treatments. Doctors will give patients specially engineered natural killer (NK) cells designed to recognize and attack cancer cells …

This is a first-in-human study testing a new type of cell therapy for adults with recurrent or progressive glioblastoma or other high-grade brain tumors. The therapy uses 'off-the-shelf' natural killer immune cells that are genetically engineered to recognize and attack two speci…

This study is testing a new type of cell therapy for people with advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors will give patients specially engineered immune cells (called CAR-NK cells) designed to recognize and attack two specifi…

This early-stage trial is testing whether specially engineered immune cells can fight advanced small cell lung cancer that has stopped responding to standard treatments. Researchers will give patients immune cells from healthy donors that have been modified to recognize and attac…

This study is testing a new type of treatment called CAR-NK cell therapy for people with advanced breast cancer that has stopped responding to standard treatments. Doctors will collect a patient's own natural immune cells, modify them in a lab to better recognize and attack cance…

This early-stage trial is testing a new type of treatment using specially engineered immune cells, called CAR-NK cells, for people with advanced pancreatic cancer that has spread or cannot be removed by surgery. The study aims to find a safe dose and see if the treatment can shri…

This study is testing a new type of treatment called CAR-NK cell therapy for women with ovarian cancer that has come back or stopped responding to standard treatments. Doctors first check the patient's tumor for specific markers and then give them a personalized infusion of modif…

This study is testing a new type of cell therapy for adults with advanced or metastatic colorectal cancer that has stopped responding to standard treatments. Doctors will give patients immune cells (CAR-NK cells) that are engineered to recognize and attack two specific proteins f…